Latest filing published 04 Jun 2013 for Fortress Biotech, Inc., €15k.
Insider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -80.9%Entry US$134.55 · Close at T+365 US$25.65
- +74.4%Entry US$73.95 · Close at T+365 US$129.00
- +5.9%Entry US$81.00 · Close at T+365 US$85.80
- -42.0%Entry US$69,300.00 · Close at T+365 US$40,200.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Noah D. Beerman: trading record in brief
Noah D. Beerman is a declared insider at 3 companies; the most frequent names are Indevus Pharmaceuticals Inc, Fortress Biotech, Inc. and SELLAS Life Sciences Group, Inc. Over a trading history stretching from 7 March 2006 to 31 May 2013, the count stands at 13 filings.
The open-market record is one-sided, with 4 purchases worth €72k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 share grants and 1 option exercise. 2013 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €19k. Ninety days after publication, 4 purchases show a median change of +18.2%, with the price up in 75% of them. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 4 June 2013, reports an open-market purchase of €15k in Fortress Biotech, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Noah D. Beerman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$3.88Common Stock, par value $0.001SEC:0001181431-13-032493:0Canonical exit: 29 Aug 2013 (T+90)
- 5,000 shares@ US$5.00Common Stock, par value $0.001SEC:0001181431-12-037984:0Canonical exit: 20 Sept 2012 (T+90)
- 5,000 shares@ US$4.99Common Stock, par value $0.001SEC:0001209191-12-003501:0Canonical exit: 11 Apr 2012 (T+90)
- 77,587 shares0Common StockSEC:0001209191-11-018776:0
- 10,000 shares@ US$2.23Common StockSEC:0001209191-10-038106:0Canonical exit: 7 Oct 2010 (T+90)
- 5,407 shares0Common StockSEC:0001209191-10-004500:0
- 100,517 sharesCommon StockSEC:0001181431-09-011276:0
- 100,443 shares0Common StockSEC:0001181431-09-011276:1
- 100,443 sharesCommon StockSEC:0001181431-09-011276:2
- 55,918 shares0Common StockSEC:0001181431-08-054744:0
- 13,500 shares0Common StockSEC:0001181431-08-005185:0
- 13,500 shares0Common StockSEC:0001181431-07-065471:0
- 28,800 shares0Common StockSEC:0001181431-06-017226:0
13 of 13 declarations